Literature DB >> 17175141

Activity of cefditoren against clinical isolates of Streptococcus pneumoniae showing non-susceptibility to penicillins, cephalosporins, macrolides, ketolides or quinolones.

Asunción Fenoll, María-José Giménez, Olga Robledo, Pilar Coronel, Mercedes Gimeno, Julio Casal, Lorenzo Aguilar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17175141     DOI： 10.1016/j.ijantimicag.2006.08.046

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  7 in total

1.  In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.

Authors:  Asunción Fenoll; Lorenzo Aguilar; Olga Robledo; María-José Giménez; Juan-José Granizo; Donald Biek; David Tarragó
Journal:  Antimicrob Agents Chemother       Date:  2008-08-25       Impact factor: 5.191

Review 2.  Multidrug-resistant Streptococcus pneumoniae infections: current and future therapeutic options.

Authors:  Françoise Van Bambeke; René R Reinert; Peter C Appelbaum; Paul M Tulkens; Willy E Peetermans
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity.

Authors:  Mototsugu Yamada; Takashi Watanabe; Takako Miyara; Nobuyoshi Baba; Jun Saito; Yasuo Takeuchi; Fukuichi Ohsawa
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

4.  Update on the clinical utility and optimal use of cefditoren.

Authors:  José Barberán; Lorenzo Aguilar; María-José Giménez
Journal:  Int J Gen Med       Date:  2012-05-21

5.  Drug resistance in community-acquired respiratory tract infections: role for an emerging antibacterial.

Authors:  Lorenzo Aguilar; María-José Giménez; José Barberán
Journal:  Infect Drug Resist       Date:  2010-06-18       Impact factor: 4.003

Review 6.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02

7.  High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.

Authors:  David Sevillano; Lorenzo Aguilar; Luis Alou; María-José Giménez; Natalia González; Martha Torrico; Fabio Cafini; Asunción Fenoll; Pilar Coronel; José Prieto
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.